Q: Who is the Best Technology Vendor? A: NONE!
An open Letter to the Life-Sciences Industry on Analyst Forced Vendor Rankings By: Daniel R. Matlis As a Life-Science Industry Analyst, I am often asked …
Latest
Pfizer Uses Positive Disruption to Manage Product Design Across the Lifecycle
COVID-19 forced Life-Science companies to reimagine the way they operate. Pfizer has adapted its Culture, Systems and Processes to drive increased visibility, control and collaboration …
Pfizer Uses Positive Disruption to Manage Product Design Across the Lifecycle Read More »
Improving Product Quality & Patient Outcomes with Integrated QRM
An Axendia Insight Brief, Presented by Sparta Systems An effective Quality and Risk Management program enables Life Science manufacturers to proactively manage product quality and …
Improving Product Quality & Patient Outcomes with Integrated QRM Read More »
AVEVA to Accelerate Growth in Life-Sciences with OSIsoft Acquisition
AVEVA Briefing Note By Daniel R. Matlis Axendia was recently briefed by Craig Hayman, CEO AVEVA and Dr. J. Patrick Kennedy, Founder and Chairman Emeritus …
AVEVA to Accelerate Growth in Life-Sciences with OSIsoft Acquisition Read More »
Digital Transformation Builds Trust Across the Value Network
Disruptions have eroded trust across Life-Science supply chains forcing brand owners to re-evaluate outsourcing programs in favor of Smart-Sourcing strategies that focus on quality, resilience, …
Digital Transformation Builds Trust Across the Value Network Read More »
Improving Process Understanding Across the Product Lifecycle
QbDVision Briefing Note By Daniel R. Matlis The Executive Management team at CherryCircle Software recently briefed Axendia on QbDVision®, its cloud-based Product Quality and Lifecycle …
Improving Process Understanding Across the Product Lifecycle Read More »
SAP Re-Imagines Supply Chain Collaboration
SAP Briefing Note By Daniel R. Matlis SAP’s Life Sciences leadership team recently briefed Axendia on its re-imagined Supply Chain Collaboration strategy. Globalization and outsourcing …
FDA Debunks Industry Myths on Electronic Batch Records and Review by Exceptions
Automating Electronic Batch Record review is a key benefit of Modernizing Manufacturing Operations. Yet concerns regarding FDA’s acceptance of Review by Exception (RBE) has prevented …
FDA Debunks Industry Myths on Electronic Batch Records and Review by Exceptions Read More »
2021 Forecast for the Life-Sciences Industry
Industry must adapt and overcome current and future disruptive trends on the horizon. To assist in this effort, Axendia revealed the 2021 Life-Sciences Radar. In …
The Horizon of AI in the Life-Sciences Industry
Aizon Briefing Note By: Sandra K. Rodriguez, Senior Market Analyst Axendia was recently briefed by the Executive Team of Aizon (formerly Bigfinite.) With headquarters in …
FDA Shares Insights on Digital Transformation & Manufacturing Modernization
The FDA has recognized that current perceptions and approaches to computer system validation (CSV) are a significant barrier to Digital Transformation and Manufacturing Modernization. The …
FDA Shares Insights on Digital Transformation & Manufacturing Modernization Read More »
Time to Invest in Bio-Pharma PLM
Selerant Briefing Note By Daniel R. Matlis The Executive Management team at Selerant recently briefed Axendia on its formula-based product lifecycle management (PLM) solution. Founded …